These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29042954)
1. Dexmedetomidine ameliorates the inflammatory immune response in rats with acute kidney damage. Liu W; Yu W; Weng Y; Wang Y; Sheng M Exp Ther Med; 2017 Oct; 14(4):3602-3608. PubMed ID: 29042954 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Tan F; Chen Y; Yuan D; Gong C; Li X; Zhou S Biomed Rep; 2015 May; 3(3):365-370. PubMed ID: 26137237 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of dexmedetomidine protection against cisplatin induced acute kidney injury in rats. Zheng ZL; Ma JW; Luo Y; Liang GJ; Lei SJ; Yan KJ; Meng HB; Liu XJ Ren Fail; 2024 Dec; 46(1):2337287. PubMed ID: 38627212 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway. Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats. Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion. Li Q; Chen C; Chen X; Han M; Li J Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264 [TBL] [Abstract][Full Text] [Related]
7. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice. Liu Y; Yu Y; Zhang J; Wang C Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201 [TBL] [Abstract][Full Text] [Related]
10. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway. Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of K Minaei A; Haghdoost-Yazdi H Toxicol Appl Pharmacol; 2019 Nov; 382():114743. PubMed ID: 31476326 [TBL] [Abstract][Full Text] [Related]
12. [Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury]. Chen YJ; Gong CL; Tan F; Zhou SL Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1472-5. PubMed ID: 26547344 [TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Relieves Acute Inflammatory Visceral Pain in Rats through the ERK Pathway, Toll-Like Receptor Signaling, and TRPV1 Channel. Liu Y; Liu W; Wang X; Wan Z; Liu Y; Leng Y J Mol Neurosci; 2018 Oct; 66(2):279-290. PubMed ID: 30259406 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway. Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Ameliorate CLP-Induced Rat Intestinal Injury via Inhibition of Inflammation. Chen Y; Miao L; Yao Y; Wu W; Wu X; Gong C; Qiu L; Chen J Mediators Inflamm; 2015; 2015():918361. PubMed ID: 26273145 [TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro. Kawasaki T; Kawasaki C; Ueki M; Hamada K; Habe K; Sata T J Trauma Acute Care Surg; 2013 May; 74(5):1370-5. PubMed ID: 23609293 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor. Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway. Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816 [TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model. Qiu R; Yao W; Ji H; Yuan D; Gao X; Sha W; Wang F; Huang P; Hei Z Life Sci; 2018 Jul; 204():1-8. PubMed ID: 29733849 [TBL] [Abstract][Full Text] [Related]